Does Methadone Affect the Liver? What MAT Patients Should Know About Liver Health

Complete Healthcare Team

If you’re on methadone and worried it might be quietly damaging your liver, here’s the reassuring answer up front: methadone itself is not toxic to the liver. Major clinical references, including the NIH’s drug-induced liver injury database, have found that methadone has not been linked to liver injury even with long-term use. The reason liver monitoring still matters during medication-assisted treatment has less to do with the medication and more to do with conditions that are common in people who’ve used opioids, especially hepatitis. Understanding that distinction helps you know what to actually watch for.

Liver health is worth paying attention to during treatment, just not for the reason many people assume. The addiction treatment team at Complete Healthcare monitors this as part of comprehensive care, and this guide explains what methadone does and doesn’t do to your liver, why monitoring is recommended anyway, and what it involves.

Can Methadone Cause Liver Damage? What the Evidence Says

The direct answer is that methadone is not considered hepatotoxic, meaning it doesn’t directly damage liver cells. The NIH LiverTox database states that methadone therapy has not been linked to serum enzyme elevations or to clinically apparent liver injury. Long-term studies of people on methadone maintenance have reached the same conclusion, finding no evidence of methadone-caused liver harm over time.

There’s an important nuance, though. The liver is central to how methadone is metabolized and cleared from the body. That means existing liver problems can affect how methadone is processed, which is one reason your provider pays attention to liver health when managing your dose. It’s not that methadone hurts the liver. It’s that the liver’s condition can influence how methadone behaves.

So Why Does Liver Monitoring Matter in MAT?

If methadone isn’t the culprit, why the attention to liver health? The answer comes down to what’s common in people entering treatment for opioid use disorder.

Chronic liver disease, particularly from hepatitis B and hepatitis C, is highly common in this population, largely because these infections spread through shared injection equipment. Some studies have found that a large share of people entering methadone treatment have evidence of chronic liver disease, most often viral hepatitis. That background rate, not the medication, is the real reason liver monitoring belongs in good MAT care.

Hepatitis C is especially relevant. It often causes no symptoms for years while quietly affecting the liver, which is why the CDC recommends testing for anyone who has ever injected drugs, along with one-time screening for all adults and periodic testing while risk continues. Catching and treating hepatitis C matters enormously, because it’s now curable in most cases with modern medications, and untreated it can lead to cirrhosis or liver cancer over time.

How Buprenorphine Compares

If you’re on buprenorphine (often known by the brand name Suboxone when combined with naloxone) rather than methadone, the liver picture is slightly different. Buprenorphine has been associated with rare cases of liver injury, particularly when it’s misused by injection rather than taken as prescribed.

For that reason, the prescribing information for buprenorphine recommends checking liver function before starting treatment to establish a baseline, and monitoring periodically during treatment. This isn’t a reason to avoid buprenorphine, which is a safe and highly effective treatment for opioid use disorder when taken as directed. It’s simply why liver monitoring is a standard part of the protocol. Taken as prescribed, the risk is low.

What Liver Monitoring Actually Involves

The good news is that monitoring is simple, low-effort, and routine. It generally includes:

• A baseline liver panel before or around when you start treatment, which measures liver enzymes like AST and ALT to establish your starting point.
• Hepatitis screening, including testing for hepatitis B and C, since these are the most common liver concerns in this setting and both are treatable.
• Periodic follow-up testing, based on your history, your medication, and whether you have an existing liver condition.

These are standard blood tests, nothing invasive. In our practice, we treat this as a normal part of caring for the whole person rather than just managing a medication, because addressing something like undiagnosed hepatitis C can change the course of someone’s long-term health.

Common Questions About Methadone and Liver Health

Is it safe to take methadone if I already have hepatitis C or liver disease?

In most cases, yes, but it requires medical oversight. Methadone can generally be used by people with hepatitis C or liver conditions, and there’s no evidence that methadone maintenance worsens the course of chronic viral hepatitis. That said, significant liver impairment can affect how your body processes methadone, so your provider may adjust your dose and monitor you more closely. This is a conversation to have openly with your care team, especially if you have a known liver condition, so your treatment can be tailored safely.

What are the signs of liver problems I should watch for?

Because liver conditions like hepatitis C often cause no symptoms early on, testing is more reliable than waiting for warning signs. That said, symptoms worth reporting to your provider include yellowing of the skin or eyes (jaundice), unusual fatigue, pain in the upper right abdomen, dark urine, pale stools, or nausea that doesn’t resolve. If any of these appear, let your care team know, though their absence doesn’t rule out a liver issue, which is exactly why routine testing matters.

Will drinking alcohol on methadone hurt my liver?

Alcohol is genuinely harder on the liver than methadone is, and combining heavy drinking with any medication adds risk. Beyond the liver, mixing alcohol with methadone is dangerous because both can suppress breathing, which raises the risk of overdose. If alcohol use is something you’re struggling with alongside opioid use, that’s worth raising with your provider, since it’s common and treatable, and it factors into keeping both you and your liver safe.

Who Should Pay Extra Attention to Liver Health

Liver monitoring is especially important for some people in treatment:

• Anyone with a history of injection drug use, given the elevated risk of hepatitis B and C
• People who have never been screened for hepatitis C, since it can go undetected for years
• People who drink alcohol regularly, which affects the liver directly
• People with a known liver condition, who benefit from closer dose management and monitoring
• People taking other medications that affect the liver, where interactions matter

If any of these apply to you, it’s worth confirming that liver screening is part of your care plan.

The Bigger Picture on Staying Well in Treatment

The most useful reframe here is that liver monitoring during MAT isn’t about protecting you from your medication. It’s about catching and treating conditions like hepatitis C that are common, often silent, and very treatable when found. For many people, entering treatment for opioid use disorder is the first time these conditions get properly diagnosed and addressed, which is one of the quieter benefits of comprehensive care.

Talk Through Your Treatment and Liver Health

If you’re in medication-assisted treatment or considering it and have questions about liver health, hepatitis screening, or how your medication fits your situation, we’re here to help you sort it out. Complete Healthcare has provided addiction treatment in Central Ohio for over 30 years, with same-day appointments available across our 11 locations, including Columbus, Pickerington, Newark, Lancaster, Marion, Marysville, and Delaware. Call us at 614-882-4343 or schedule online to get started.